HilleVax, Inc.
NASDAQ:HLVX
1.88 (USD) • At close April 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 2.864 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0.795 | 0.707 | 0.724 | 0.653 | 0.418 | 0 | 2.252 | 0 | 0 | 0 | 0.002 | 0 | 0.001 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | -0.795 | -0.707 | 2.14 | -0.653 | -0.418 | 0 | -2.252 | 0 | 0 | 0 | -0.002 | 0 | -0.001 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0.747 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.428 | 20.165 | 26.601 | 25.978 | 33.258 | 27.308 | 22.953 | 23.164 | 17.556 | 13.315 | 8.826 | 6.211 | 8.391 | 0.896 | 0.46 | 0.267 | 0 | 0 |
| General & Administrative Expenses
| 5.951 | 6.215 | 8.127 | 8.494 | 7.033 | 6.603 | 7.231 | 5.795 | 5.543 | 4.577 | 3.982 | 2.603 | 2.692 | 1.113 | 0.753 | 1.198 | 0.445 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | -0.795 | -0.707 | -0.724 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.951 | 6.215 | 7.332 | 7.787 | 6.309 | 6.603 | 7.231 | 5.795 | 5.543 | 4.577 | 3.982 | 2.603 | 2.692 | 1.113 | 0.753 | 1.198 | 0.445 | 0.633 |
| Other Expenses
| 24.772 | 0 | 1.335 | 1.293 | 1.068 | 2.096 | 0.329 | 0 | 1.911 | -0.025 | -34.416 | -17.091 | -18.831 | -0.878 | -0.446 | -0.072 | 0 | 0 |
| Operating Expenses
| 36.151 | 26.38 | 33.933 | 33.765 | 39.567 | 33.911 | 30.184 | 28.959 | 23.099 | 17.892 | 12.808 | 8.814 | 11.083 | 2.009 | 1.213 | 1.465 | 0.445 | 0.633 |
| Operating Income
| -36.151 | -26.38 | -34.728 | -34.472 | -40.291 | -33.911 | -30.184 | -28.959 | -23.099 | -17.892 | -12.808 | -11.314 | -11.073 | -39.675 | -1.213 | -1.465 | -0.445 | -0.633 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -14.068 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.204 | 0.557 | 2.295 | -12.357 | 3.331 | 2.096 | 2.282 | 2.07 | 1.911 | 1.087 | -41.121 | -56.573 | -26.254 | -22.193 | -0.454 | -0.081 | -0.274 | -0.04 |
| Income Before Tax
| -33.947 | -25.823 | -40.668 | -46.829 | -36.96 | -31.815 | -27.902 | -26.889 | -21.188 | -16.805 | -53.929 | -67.887 | -37.327 | -61.868 | -1.667 | -1.546 | -0.719 | -0.673 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -12.905 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0.664 | 2.704 | -0.653 | 0.829 | 0 | -1.911 | -1.292 | 41.121 | 54.509 | -16.721 | -36.949 | 0.008 | 0.009 | -0.445 | 0 |
| Net Income
| -33.947 | -25.823 | -40.668 | -46.829 | -36.96 | -31.815 | -27.902 | -26.889 | -19.277 | -15.513 | -95.05 | -122.396 | -37.327 | -61.868 | -1.667 | -1.546 | -0.719 | -0.673 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -12.905 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.68 | -0.52 | -0.83 | -0.97 | -0.78 | -0.81 | -0.74 | -0.71 | -0.51 | -0.42 | -3.59 | -4.05 | -2.29 | -3.8 | -0.1 | -0.095 | -0.024 | -0.022 |
| EPS Diluted
| -0.68 | -0.52 | -0.83 | -0.97 | -0.78 | -0.81 | -0.74 | -0.71 | -0.51 | -0.42 | -3.59 | -4.05 | -2.29 | -3.8 | -0.1 | -0.095 | -0.024 | -0.022 |
| EBITDA
| -33.093 | -23.128 | -39.135 | -45.395 | -35.51 | -30.445 | -26.984 | -26.079 | -18.679 | -16.6 | -53.041 | -65.823 | -35.215 | -2.887 | -1.658 | -1.537 | -0.266 | -0.664 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -12.399 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |